Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

INTRODUCTION: End-stage kidney disease (ESKD) is a major public health problem affecting more than 2 million people worldwide. It is one of the most severe chronic non-communicable diseases. Haemodialysis (HD) is the most common therapeutic option but is also associated with a risk of cardiovascular...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Open
Prif Awduron: Blankestijn, Peter J, Fischer, Kathrin I, Barth, Claudia, Cromm, Krister, Canaud, Bernard, Davenport, Andrew, Grobbee, Diederick E, Hegbrant, Jörgen, Roes, Kit C, Rose, Matthias, Strippoli, Giovanni FM, Vernooij, Robin WM, Woodward, Mark, de Wit, G Ardine, Bots, Michiel L
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Renal Medicine
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7044930/
https://ncbi.nlm.nih.gov/pubmed/32029487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-033228
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg